Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322473/
https://www.ncbi.nlm.nih.gov/pubmed/37416199
http://dx.doi.org/10.1155/2023/9804984
_version_ 1785068763601698816
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10322473
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103224732023-07-06 Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322473/ /pubmed/37416199 http://dx.doi.org/10.1155/2023/9804984 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title_full Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title_fullStr Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title_full_unstemmed Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title_short Retracted: Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma
title_sort retracted: timosaponin aiii suppresses rap1 signaling pathway to enhance the inhibitory effect of paclitaxel on nasopharyngeal carcinoma
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322473/
https://www.ncbi.nlm.nih.gov/pubmed/37416199
http://dx.doi.org/10.1155/2023/9804984
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedtimosaponinaiiisuppressesrap1signalingpathwaytoenhancetheinhibitoryeffectofpaclitaxelonnasopharyngealcarcinoma

Ejemplares similares